Dr. Calvi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
601 Elmwood Ave
# 320
Rochester, NY 14642Phone+1 585-275-2901Fax+1 585-273-1288
Education & Training
- Massachusetts General HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1998 - 2000
- Massachusetts General HospitalResidency, Internal Medicine, 1995 - 1998
- Harvard Medical SchoolClass of 1995
Certifications & Licensure
- NY State Medical License 2002 - 2025
- MA State Medical License 2000 - 2002
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- 585 Magazine Castle Connolly, 2012
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Publications & Presentations
PubMed
- 8 citationsEfferocytosis by bone marrow mesenchymal stromal cells disrupts osteoblastic differentiation via mitochondrial remodeling.Emily R Quarato, Noah A Salama, Allison J Li, Charles O Smith, Jane Zhang
Cell Death & Disease. 2023-07-14 - 159 citationsFunctional inhibition of osteoblastic cells in an in vivo mouse model of myeloid leukemiaBenjamin J. Frisch, John M. Ashton, Lianping Xing, Michael W. Becker, Craig T. Jordan
Blood. 2011-11-18 - 491 citationsOsteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size.Sebastian Stier, Yon Ko, Randolf Forkert, Christoph Lutz, Thomas Neuhaus
The Journal of Experimental Medicine. 2005-06-06
Abstracts/Posters
- Local Irradiation Induces Systemic Inflammatory Response and Alteration of the Hematopoietic Stem Cell NicheLaura M. Calvi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- A Specific Mesenchymal Stem and Progenitor Cell (MSPC) Subpopulation with a Multi-Potent Gene Signature Is Transcriptionally Altered in the Setting of Myelodysplastic ...Laura M. Calvi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
- Wilmot Cancer Institute Secures $13.6 Million in GrantsAugust 8th, 2022
- Named Positions Celebrate the Work of Rochester’s FacultyFebruary 8th, 2021
- Delving Where Few Others Have Gone, Leukemia Researchers Open New PathOctober 15th, 2018
Grant Support
- Hematopoietic-Osteoblastic InteractionsNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2012
- Bone Marrow - Mitigation Of Bone Marrow Radiation InjuryNational Institute Of Allergy And Infectious Diseases2010–2011
- Regulatory Cell Signals In The Bone MarrowNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2011
- Roles Of Pth/Pthrp Receptors In Osteoblastic CellsNational Institute Of Diabetes And Digestive And Kidney Diseases2002–2006
- Osteoblastic Activation In The Hematopoietic Stem CellNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2005
- Roles Of Pth/Pthrp Receptors In OsteoblastsNational Institute Of Diabetes And Digestive And Kidney Diseases2001
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: